CHR vs PAVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 25, 2026

CHR

62.1
AI Score
VS
CHR Wins

PAVS

42.0
AI Score

Investment Advisor Scores

CHR

62score
Recommendation
BUY

PAVS

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CHR PAVS Winner
Revenue 148.84M 14.60M CHR
Net Income 25.62M -12.73M CHR
Net Margin 17.2% -87.2% CHR
Operating Income 26.29M -14.66M CHR
ROE 6.9% -40.8% CHR
ROA 6.4% -34.5% CHR
Total Assets 401.69M 36.87M CHR
Cash 242.08M 10.30M CHR
Current Ratio 11.53 8.18 CHR

Relative Price Performance (Last 90 Days)

CHR 1M: -4.6% · 3M: +3.9% PAVS 1M: +6.6% · 3M: +395.2%

Current Technical Phase

CHR

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -4.5%) with fading momentum, RSI 50

RSI (14): 49.6 · Price: $1.88

PAVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $5.15

Fundamentals Snapshot

Metric CHR PAVS
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 708.0%
Gross Margin 0.7% 0.2%
Operating Margin 0.2% -1.3%
EPS -23.29 -2063.90
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CHR is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.